MEP Stelios Kympouropoulos (EPP, Greece) hosted a policy breakfast roundtable titled ‘Doing better for Europe’s NCD population: earlier intervention to transform outcomes for people and planet.’ The event, held in collaboration with AstraZeneca, addressed non-communicable diseases (NCDs) and their impact on Europe.

Among the participants, Daniel Gallego, President of the European Kidney Patients’ Federation, and Juan Carlos Julián Mauro, Managing Director of the Spanish Kidney Patients’ Federation (ALCER), shared insights on early intervention and detection of Chronic Kidney Disease (CKD) and its potential to reduce the disease’s socio-economic and environmental impact.

Daniel Gallego emphasized how early detection and intervention in CKD can significantly improve outcomes for patients and alleviate the burden on healthcare systems. His perspective bridged the European and Spanish context, offering valuable insights into best practices and the impact of political action.

Juan Carlos Julián Mauro discussed successful partnership efforts to update Spain’s national CKD plan and its focus on prevention and early detection. He also highlighted regional programs and pilots aimed at implementing the strategy in Spain.

The policy roundtable aimed to encourage open dialogue and collaboration among EU institutions, non-governmental organizations, patient groups, and industry stakeholders working in the field of EU health policy. The event focused on the pressing issue of CKD and its impact on both people and the planet, underlining the importance of early intervention as a means to transform outcomes for Europe’s NCD population.